117 related articles for article (PubMed ID: 3257999)
1. Characterization of the mononuclear infiltrate in basal cell carcinoma: a predominantly T cell-mediated immune response with minor participation of Leu-7+ (natural killer) cells and Leu-14+ (B) cells.
Habets JM; Tank B; Vuzevski VD; van Reede EC; Stolz E; van Joost T
J Invest Dermatol; 1988 Mar; 90(3):289-92. PubMed ID: 3257999
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the mononuclear infiltrate in Bowen's disease (squamous cell carcinoma in situ). Evidence for a T cell-mediated anti-tumour immune response.
Habets JM; Tank B; van Joost T
Virchows Arch A Pathol Anat Histopathol; 1989; 415(2):125-30. PubMed ID: 2500767
[TBL] [Abstract][Full Text] [Related]
3. Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon.
Mozzanica N; Cattaneo A; Boneschi V; Brambilla L; Melotti E; Finzi AF
Arch Dermatol Res; 1990; 282(5):311-7. PubMed ID: 2221983
[TBL] [Abstract][Full Text] [Related]
4. In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.
De Giorgi V; Salvini C; Chiarugi A; Paglierani M; Maio V; Nicoletti P; Santucci M; Carli P; Massi D
Int J Dermatol; 2009 Mar; 48(3):312-21. PubMed ID: 19261026
[TBL] [Abstract][Full Text] [Related]
5. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
Habets JM; Tank B; Vuzevski VD; Stolz E; van Joost T
J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis.
Senaldi G; Portmann B; Mowat AP; Mieli-Vergani G; Vergani D
Arch Dis Child; 1992 Dec; 67(12):1447-53. PubMed ID: 1489223
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic analysis of the transformation zone of human cervix.
Roncalli M; Sideri M; Giè P; Servida E
Lab Invest; 1988 Feb; 58(2):141-9. PubMed ID: 2448545
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
9. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
10. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.
Buechner SA
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):731-4. PubMed ID: 1869644
[TBL] [Abstract][Full Text] [Related]
11. Impairments in functional subsets of T-suppressor (CD8) lymphocytes, monocytes, and natural killer cells among asbestos-exposed workers.
Tsang PH; Chu FN; Fischbein A; Bekesi JG
Clin Immunol Immunopathol; 1988 Jun; 47(3):323-32. PubMed ID: 2967138
[TBL] [Abstract][Full Text] [Related]
12. The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers.
Tollerud DJ; Clark JW; Brown LM; Neuland CY; Pankiw-Trost LK; Blattner WA; Hoover RN
J Clin Immunol; 1989 May; 9(3):214-22. PubMed ID: 2788656
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
Kansas GS; Wood GS; Fishwild DM; Engleman EG
J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924
[TBL] [Abstract][Full Text] [Related]
14. Immunoelectron microscopic application of monoclonal antibodies for identification of lymphocyte subsets bearing tubuloreticular inclusions or parallel tubular arrays.
Kang YH; Yaffe L; Grimley PM
J Exp Pathol; 1984; 1(2):157-73. PubMed ID: 6100980
[TBL] [Abstract][Full Text] [Related]
15. [Immunophenotyping and morphometry of inflammatory infiltrates in variants of basalioma].
Ernst TM; Müller-Mai C
Z Hautkr; 1987 Aug; 62(15):1134, 1137-40, 1143-4. PubMed ID: 3314210
[TBL] [Abstract][Full Text] [Related]
16. Immunohistologic studies of squamous cell carcinoma: possible participation of Leu-7+ (natural killer) cells as antitumor effector cells.
Kohchiyama A; Oka D; Ueki H
J Invest Dermatol; 1986 Oct; 87(4):515-8. PubMed ID: 3093594
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
Kooy AJ; Prens EP; Van Heukelum A; Vuzevski VD; Van Joost T; Tank B
J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
[TBL] [Abstract][Full Text] [Related]
18. [Parapsoriasis en plaques. Characterization of the cellular infiltrate using monoclonal antibodies].
Büchner SA
Z Hautkr; 1988 May; 63(5):423-4, 427-9. PubMed ID: 3043952
[TBL] [Abstract][Full Text] [Related]
19. Phenotype of recovering lymphoid cell populations after marrow transplantation.
Ault KA; Antin JH; Ginsburg D; Orkin SH; Rappeport JM; Keohan ML; Martin P; Smith BR
J Exp Med; 1985 Jun; 161(6):1483-502. PubMed ID: 3159819
[TBL] [Abstract][Full Text] [Related]
20. Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+3+ subpopulation.
Preffer FI; Colvin RB; Leary CP; Boyle LA; Tuazon TV; Lazarovits AI; Cosimi AB; Kurnick JT
J Immunol; 1986 Nov; 137(9):2823-30. PubMed ID: 3093583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
